Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In December 2019, the coronavirus disease 2019 (COVID-19) outbreak occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID-19 are limited.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Allergy Clin Immunol

Title: The Journal of allergy and clinical immunology

Publisher: Elsevier BV

ISSN (Electronic): 1097-6825

ISSN (Print): 0091-6749

Publication date (Electronic): Jul 2020

Volume: 146

Issue: 1

Affiliations

[1 ] Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Respiratory Diseases, National Ministry of Health of the People's Republic of China and National Clinical Research Center for Respiratory Disease, Wuhan, China.

[2 ] United Imaging Healthcare Co Ltd, Wuhan, China.

[3 ] School of Medicine and Health Management, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

[4 ] Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg University Hospital Giessen and Marburg GmbH, Marburg, Germany.

[5 ] Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Respiratory Diseases, National Ministry of Health of the People's Republic of China and National Clinical Research Center for Respiratory Disease, Wuhan, China. Electronic address: xie_m@126.com.

[6 ] Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Respiratory Diseases, National Ministry of Health of the People's Republic of China and National Clinical Research Center for Respiratory Disease, Wuhan, China. Electronic address: zhaojp88@126.com.

Article

Publisher Item ID: S0091-6749(20)30495-4

DOI: 10.1016/j.jaci.2020.04.006

PMC ID: 7152876

PubMed ID: 32294485

SO-VID: bb4ba263-611c-4481-931a-3210c924a920

History

Keywords: COVID-19,SARS-CoV-2,mortality,risk factors,severity

Data availability:

Keywords: COVID-19, SARS-CoV-2, mortality, risk factors, severity

Comments

Comment on this article

scite_

Cited by 1,039

See all cited by

- Version 1
- Version 1